Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma
Status:
Completed
Trial end date:
2019-09-11
Target enrollment:
Participant gender:
Summary
The objectives of this study are:
- To evaluate the efficacy of Phentolamine Mesylate to lower intra-ocular pressure (IOP)
in the treatment of Open-Angle Glaucoma (OAG) and Ocular Hypertension (OHT).
- To evaluate the ocular and systemic safety of Phentolamine Mesylate compared to its
vehicle.
- To evaluate additional efficacy of Phentolamine Mesylate to improve visual performance.